182 related articles for article (PubMed ID: 19265701)
21. Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.
Hu L; Ding M; Tang D; Gao E; Li C; Wang K; Qi B; Qiu J; Zhao H; Chang P; Fu F; Li Y
Theranostics; 2019; 9(13):3687-3706. PubMed ID: 31281507
[TBL] [Abstract][Full Text] [Related]
22. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
[TBL] [Abstract][Full Text] [Related]
23. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
Yu H; Guo Y; Mi L; Wang X; Li L; Gao W
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):205-11. PubMed ID: 21106870
[TBL] [Abstract][Full Text] [Related]
24. Regulation of mitofusin-2 expression in skeletal muscle.
Zorzano A
Appl Physiol Nutr Metab; 2009 Jun; 34(3):433-9. PubMed ID: 19448711
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2.
Tang H; Tao A; Song J; Liu Q; Wang H; Rui T
Int J Biochem Cell Biol; 2017 Jul; 88():55-59. PubMed ID: 28483668
[TBL] [Abstract][Full Text] [Related]
26. The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.
Sorianello E; Soriano FX; Fernández-Pascual S; Sancho A; Naon D; Vila-Caballer M; González-Navarro H; Portugal J; Andrés V; Palacín M; Zorzano A
Cardiovasc Res; 2012 Apr; 94(1):38-47. PubMed ID: 22253285
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor AP1 binds the functional region of the promoter and regulates gene expression of human PPARdelta in LoVo cell.
Jiang X; Yang X; Han Y; Lu S
Tumour Biol; 2013 Dec; 34(6):3619-25. PubMed ID: 23832539
[TBL] [Abstract][Full Text] [Related]
28. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of cardiac hypertrophy by mitofusin 2 in neonatal rat cardiomyocytes].
Chen CL; Shen T; Zheng M; Guo YH; Zhu XJ; Chen GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):528-32. PubMed ID: 18931719
[TBL] [Abstract][Full Text] [Related]
30. Mitofusin 2 decreases intracellular lipids in macrophages by regulating peroxisome proliferator-activated receptor-γ.
Liu C; Ge B; He C; Zhang Y; Liu X; Liu K; Qian C; Zhang Y; Peng W; Guo X
Biochem Biophys Res Commun; 2014 Jul; 450(1):500-6. PubMed ID: 24928385
[TBL] [Abstract][Full Text] [Related]
31. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function.
Kleiner S; Nguyen-Tran V; Baré O; Huang X; Spiegelman B; Wu Z
J Biol Chem; 2009 Jul; 284(28):18624-33. PubMed ID: 19435887
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial fusion and maintenance of mitochondrial homeostasis in diabetic retinopathy.
Duraisamy AJ; Mohammad G; Kowluru RA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1617-1626. PubMed ID: 30922813
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
[TBL] [Abstract][Full Text] [Related]
34. Hyperglycemia Induces Endoplasmic Reticulum Stress in Atrial Cardiomyocytes, and Mitofusin-2 Downregulation Prevents Mitochondrial Dysfunction and Subsequent Cell Death.
Yuan M; Gong M; Zhang Z; Meng L; Tse G; Zhao Y; Bao Q; Zhang Y; Yuan M; Liu X; Li G; Liu T
Oxid Med Cell Longev; 2020; 2020():6569728. PubMed ID: 33149811
[TBL] [Abstract][Full Text] [Related]
35. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity.
Yeh JN; Yue Y; Chu YC; Huang CR; Yang CC; Chiang JY; Yip HK; Guo J
Biomed Pharmacother; 2021 Dec; 144():112244. PubMed ID: 34601193
[TBL] [Abstract][Full Text] [Related]
36. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.
Thulin P; Glinghammar B; Skogsberg J; Lundell K; Ehrenborg E
Int J Mol Med; 2008 Jun; 21(6):819-24. PubMed ID: 18506377
[TBL] [Abstract][Full Text] [Related]
37. Increase of peroxisome proliferator-activated receptor δ (PPARδ) by digoxin to improve lipid metabolism in the heart of diabetic rats.
Chen ZC; Yu BC; Chen LJ; Cheng JT
Horm Metab Res; 2013 May; 45(5):364-71. PubMed ID: 23225238
[TBL] [Abstract][Full Text] [Related]
38. PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscle.
Hondares E; Pineda-Torra I; Iglesias R; Staels B; Villarroya F; Giralt M
Biochem Biophys Res Commun; 2007 Mar; 354(4):1021-7. PubMed ID: 17275789
[TBL] [Abstract][Full Text] [Related]
39. G protein coupled receptor kinase 2 interacting protein 1 (GIT1) is a novel regulator of mitochondrial biogenesis in heart.
Pang J; Xu X; Getman MR; Shi X; Belmonte SL; Michaloski H; Mohan A; Blaxall BC; Berk BC
J Mol Cell Cardiol; 2011 Nov; 51(5):769-76. PubMed ID: 21756914
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]